---
title: "CF PharmTech Launches Discounted HK$300 Million H-Share Placing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294425876.md"
description: "CF PharmTech Inc. (HK:2652) announced a discounted H-share placing of approximately HK$300 million. The company will issue 21,747,700 new shares at HK$13.82 each, representing a ~12% discount to recent market prices. This transaction dilutes existing holdings by about 5.30%. Gross proceeds are expected to be HK$300.55 million, with net proceeds around HK$294.81 million, subject to standard completion conditions."
datetime: "2026-07-30T23:07:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294425876.md)
  - [en](https://longbridge.com/en/news/294425876.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294425876.md)
generator: "portal-rs"
---

# CF PharmTech Launches Discounted HK$300 Million H-Share Placing

CF PharmTech. Inc. Class H ( (HK:2652) ) has shared an announcement.

CF PharmTech, Inc. has agreed to place 21,747,700 new H shares through a syndicate of placing agents under its existing general mandate. The shares, each with a nominal value of RMB1.00, represent about 7.23% of its H shares in issue and about 5.30% of total shares before the transaction, modestly diluting existing holders.

The placing price is set at HK$13.82 per H share, reflecting discounts of around 12% to both the last closing price and the recent five‑day average. Assuming full placement, CF PharmTech expects gross proceeds of about HK$300.55 million and net proceeds of approximately HK$294.81 million, with completion still subject to conditions, prompting a cautionary note to shareholders and potential investors. 

**More about CF PharmTech. Inc. Class H**

CF PharmTech, Inc. is a joint stock company incorporated in the People’s Republic of China and listed in Hong Kong under stock code 2652. The company issues H shares to international investors via the Hong Kong Stock Exchange, using capital markets to support its pharmaceutical operations and growth strategy.

**Average Trading Volume:** 603,238

**Technical Sentiment Signal:** Strong Sell

**Current Market Cap:** HK$6.45B

Find detailed analytics on 2652 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [02652.HK](https://longbridge.com/en/quote/02652.HK.md)

## Related News & Research

- [CF PharmTech prices HK$ 300.55 million H-share placement at HK$ 13.82 each](https://longbridge.com/en/news/294424916.md)
- [UBS Reaffirms Their Buy Rating on NIO Inc. Class A (9866)](https://longbridge.com/en/news/298690881.md)
- [Herzfeld Credit Income Fund, Inc. declares $0.17 dividend](https://longbridge.com/en/news/298916705.md)
- [Nelly Group AB (OMXSTO:NELLY) Buys Back 143,000 Shares in Week 37](https://longbridge.com/en/news/298942782.md)
- [Winthrop Wealth Named to the 2026 Inc. 5000](https://longbridge.com/en/news/298932734.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**